Dr. Marty Makary

And it's basically a nonstop running pharma advertisement with an occasional insertion of some news. And then we got to go right back to break. And then it's more singing and dancing. Are these claims, are they creating an accurate picture of the claims of the medication?

And it's basically a nonstop running pharma advertisement with an occasional insertion of some news. And then we got to go right back to break. And then it's more singing and dancing. Are these claims, are they creating an accurate picture of the claims of the medication?

And so we're looking at everything. We're looking at direct-to-consumer ads. Yep. Meaning potentially banning those? We would not ban them, but we have the ability to assess whether or not they're providing an accurate picture for the viewer.

And so we're looking at everything. We're looking at direct-to-consumer ads. Yep. Meaning potentially banning those? We would not ban them, but we have the ability to assess whether or not they're providing an accurate picture for the viewer.

And so we're looking at everything. We're looking at direct-to-consumer ads. Yep. Meaning potentially banning those? We would not ban them, but we have the ability to assess whether or not they're providing an accurate picture for the viewer.

And honestly, I don't even know if these companies are trying to entice people to use their products or they're just channeling money to all the news outlets.

And honestly, I don't even know if these companies are trying to entice people to use their products or they're just channeling money to all the news outlets.

And honestly, I don't even know if these companies are trying to entice people to use their products or they're just channeling money to all the news outlets.

Yeah, it's tricky because on one hand, we believe in the First Amendment. And on the other hand, we don't, as an FDA, we don't want a company to misrepresent their product to the public. I mean, the process that they go through to get approved by the FDA includes a part where they have to show what their claims are to the public. And are they creating a notion

Yeah, it's tricky because on one hand, we believe in the First Amendment. And on the other hand, we don't, as an FDA, we don't want a company to misrepresent their product to the public. I mean, the process that they go through to get approved by the FDA includes a part where they have to show what their claims are to the public. And are they creating a notion

Yeah, it's tricky because on one hand, we believe in the First Amendment. And on the other hand, we don't, as an FDA, we don't want a company to misrepresent their product to the public. I mean, the process that they go through to get approved by the FDA includes a part where they have to show what their claims are to the public. And are they creating a notion

That if you just take our drug, you're going to be singing and dancing and playing the banjo and on jet skis and, you know, nonstop. I mean, I watch these things are so convincing. Yes. You know, I don't even know what the drug is for sometimes. And I'll be like, OK, I'll take it. I give up. I give up. I'll take it.

That if you just take our drug, you're going to be singing and dancing and playing the banjo and on jet skis and, you know, nonstop. I mean, I watch these things are so convincing. Yes. You know, I don't even know what the drug is for sometimes. And I'll be like, OK, I'll take it. I give up. I give up. I'll take it.

That if you just take our drug, you're going to be singing and dancing and playing the banjo and on jet skis and, you know, nonstop. I mean, I watch these things are so convincing. Yes. You know, I don't even know what the drug is for sometimes. And I'll be like, OK, I'll take it. I give up. I give up. I'll take it.

So pharma and industry had people as members of our FDA advisory committees. In other words, some of the FDA advisor, almost all the FDA advisory committees had a pharma or industry employee as a member of the FDA advisory committees. One of the first things I did is I removed all industry and pharma members of FDA advisory committees wherever statutorily possible.

So pharma and industry had people as members of our FDA advisory committees. In other words, some of the FDA advisor, almost all the FDA advisory committees had a pharma or industry employee as a member of the FDA advisory committees. One of the first things I did is I removed all industry and pharma members of FDA advisory committees wherever statutorily possible.

So pharma and industry had people as members of our FDA advisory committees. In other words, some of the FDA advisor, almost all the FDA advisory committees had a pharma or industry employee as a member of the FDA advisory committees. One of the first things I did is I removed all industry and pharma members of FDA advisory committees wherever statutorily possible.

We have to have a scientific process that's impeccably independent. At the same time, we can partner with America's pharma developers and inventors and create a user-friendly process for them, streamline the process. One of our goals is to deliver more cures for the American public, and there's amazing stuff now for neurodegenerative diseases, for diabetes.

We have to have a scientific process that's impeccably independent. At the same time, we can partner with America's pharma developers and inventors and create a user-friendly process for them, streamline the process. One of our goals is to deliver more cures for the American public, and there's amazing stuff now for neurodegenerative diseases, for diabetes.

We have to have a scientific process that's impeccably independent. At the same time, we can partner with America's pharma developers and inventors and create a user-friendly process for them, streamline the process. One of our goals is to deliver more cures for the American public, and there's amazing stuff now for neurodegenerative diseases, for diabetes.